14th International SCWD Digital Conference on Cachexia, Sarcopenia and Muscle Wasting

Pluristem Chief Medical Officer Dr. Nitsan Halevy will be speaking at the “Progress in Therapeutics” session which will take place on Sunday 12 December 10:20am-12:00pm EST.

Benzinga Global Small Cap Conference

CEO and President Mr. Yaky Yanay will be speaking on December 9, 2021 at 11:30am EST.

KOL Muscle Regeneration Following Hip Fracture Surgery Phase III Completed Enrollment online event

November 22, 2021

For a full recording of the webcast click here

For the full presentation click here

For the transcript click here

Israel-Taiwan Cell Therapy Development Trend

Tuesday, November 23, 2021, 2 am EST/9 am IST

Topic: Placenta cell therapy to treat ARDS associated with Covid19

CEO and President Mr. Yaky Yanay

Watch the presentation here

Q4 Investor Summit

Tuesday, November 16, 2021, 8:00am EDT/3:00pm IST

CFO Mrs. Chen Franco-Yehuda

H.C. Wainwright 7th Annual Israel Conference

Monday, November 15, 2021, 7:30am EDT/2:30pm IST

CEO and President Mr. Yaky Yanay

Improvate International Innovation Forum, Jerusalem

CEO and President Mr. Yaky Yanay will be speaking on the TED stage

The Abraham Accords, a Catalyst for Business: One Year Later – How have Israel, UAE, Bahrain and Beyond Benefited?

Wednesday, November 17, 2021, 11:00 a.m. EST

CFO Mrs. Chen Yehuda-Franco

Advanced Therapies Congress & Expo

Considerations in large scale manufacturing to achieve Off-the-Shelf Products

Track 3: Manufacture & bioprocess

14:00-14:15 BST

Mr. Lior Raviv, VP Development & Operations

A.G.P.’s Virtual Biotech & Specialty Pharma Conference, Virtual Conference

Panel topic: Covid & Covid Variants –  How to Tackle the Still Ongoing Pandemic

Led by: James Molloy, Managing Director of Equity Research Biotechnology & Specialty Pharmaceuticals

Wednesday, October 13, 2021, 12pm EST

©2023 Pluri Inc.

©2023 Pluri Inc., its logo, brand, product, and process names appearing in this issue are the trademarks of Pluri™ Inc. or its affiliated companies. All other brand, product, and process names appearing are the trademarks of their respective holders. Reference to or use of a product, or process other than those of Pluri™ Inc. does not imply recommendation, approval, affiliation, or sponsorship of that product, or process by Pluri™ Inc. Nothing contained herein shall be construed as conferring by implication, estoppel, or otherwise any license or right under any patent, copyright, trademark, or other intellectual property right of Pluri™ Inc. or any third party, except as expressly granted herein.  All information herein is for general information only and is subject for change without notice.

NAME

Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.